Clinical Trial Update: Pegaferon and Ribavirin for Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial of Pegaferon plus Ribavirin for Hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegaferon (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED